Plate IV.462 · Publications
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
Article in Leukemia, 4 July 2016.
Abstract
The sources the site reads carry no abstract for this work. The publisher's page has the full text.
Cite
@article{theis2016clinical,
title = {{Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group}},
author = {Theis, F and Corbacioglu, A and Gaidzik, V I and Paschka, P and Weber, D and Bullinger, L and Heuser, M and Ganser, A and Thol, F and Schlegelberger, B and Göhring, G and Köhne, C-H and Germing, U and Brossart, P and Horst, H-A and Haase, D and Götze, K and Ringhoffer, M and Fiedler, W and Nachbaur, D and Kindler, T and Held, G and Lübbert, M and Wattad, M and Salih, H R and Krauter, J and Döhner, H and Schlenk, R F and Döhner, K},
journal = {Leukemia},
publisher = {Springer Science and Business Media LLC},
year = {2016},
month = jul,
doi = {10.1038/leu.2016.185},
url = {https://doi.org/10.1038/leu.2016.185},
pmid = {27375010}
}